Using Atypical Antipsychotics in Primary Care.
出版信息
Prim Care Companion J Clin Psychiatry. 2002 Dec;4(6):233-241.
Abstract
摘要
相似文献
1
Using Atypical Antipsychotics in Primary Care.
Prim Care Companion J Clin Psychiatry. 2002 Dec;4(6):233-241.
2
Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
J Ment Health Policy Econ. 2008 Jun;11(2):89-97.
3
Atypical antipsychotic prescribing in elderly patients with depression.
Res Social Adm Pharm. 2018 Jul;14(7):645-652. doi: 10.1016/j.sapharm.2017.07.013. Epub 2017 Aug 2.
4
Continuation Rate of Atypical Antipsychotics After Discharge When Initiated in the Intensive Care Unit.
J Pharm Pract. 2017 Jun;30(3):342-346. doi: 10.1177/0897190016645026. Epub 2016 Apr 28.
5
Long-acting atypical antipsychotics in schizophrenia: A systematic review and meta-analyses of effects on functional outcome.
Aust N Z J Psychiatry. 2019 Jun;53(6):509-527. doi: 10.1177/0004867419837358. Epub 2019 Apr 8.
6
All-cause mortality associated with atypical and typical antipsychotics in demented outpatients.
Pharmacoepidemiol Drug Saf. 2007 May;16(5):538-44. doi: 10.1002/pds.1334.
7
A prescription survey of the use of atypical antipsychotics for hospital inpatients in the United Kingdom.
Int J Psychiatry Clin Pract. 2000;4(1):41-6. doi: 10.1080/13651500052048749.
8
Hospitalization and cost after switching from atypical to typical antipsychotics in schizophrenia patients in Thailand.
Clinicoecon Outcomes Res. 2016 Apr 29;8:127-36. doi: 10.2147/CEOR.S97300. eCollection 2016.
9
Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.
J Manag Care Pharm. 2012 Jun;18(5 Suppl B):S1-20. doi: 10.18553/jmcp.2012.18.S5-B.1.
10
Review of atypical antipsychotics in anxiety.
Eur Neuropsychopharmacol. 2011 Jun;21(6):429-49. doi: 10.1016/j.euroneuro.2010.12.007. Epub 2011 Feb 22.
本文引用的文献
1
Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial.
Am J Psychiatry. 2004 Jun;161(6):1057-65. doi: 10.1176/appi.ajp.161.6.1057.
2
Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study.
Am J Psychiatry. 2002 Oct;159(10):1777-9. doi: 10.1176/appi.ajp.159.10.1777.
3
Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence.
Am J Psychiatry. 2002 Aug;159(8):1337-46. doi: 10.1176/appi.ajp.159.8.1337.
4
Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
Am J Psychiatry. 2002 Jul;159(7):1146-54. doi: 10.1176/appi.ajp.159.7.1146.
5
Quetiapine augmentation in patients with treatment resistant obsessive-compulsive disorder: a single-blind, placebo-controlled study.
Int Clin Psychopharmacol. 2002 May;17(3):115-9. doi: 10.1097/00004850-200205000-00004.
6
Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia.
Arch Gen Psychiatry. 2002 Apr;59(4):337-45. doi: 10.1001/archpsyc.59.4.337.
7
Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia.
Am J Psychiatry. 2002 Apr;159(4):561-6. doi: 10.1176/appi.ajp.159.4.561.
8
A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia.
N Engl J Med. 2002 Jan 3;346(1):16-22. doi: 10.1056/NEJMoa002028.
9
Olanzapine treatment for post-traumatic stress disorder: an open-label study.
Int Clin Psychopharmacol. 2001 Nov;16(6):331-7. doi: 10.1097/00004850-200111000-00003.
10
Quetiapine alone and added to a mood stabilizer for serious mood disorders.
J Clin Psychiatry. 2001 Sep;62(9):728-32. doi: 10.4088/jcp.v62n0911.
Zotero 插件